Abstract：
Benign prostate hyperplasia (BPH) affects a large number of men and can be treated with behavioral, medical, or surgical treatments. The newest addition to medical therapy is β3-agonists for overactive lower urinary tract symptoms. Multiple new surgical treatments have become available in the past decade, including several clinic-based minimally invasive surgical techniques (eg, UroLift, Rezum, Optilume BPH), OR treatments (eg, Aquablation, single port robotics), and prostate artery embolization. The growth of options allows providers to better tailor BPH treatment to the specific disease factors and patient preferences.
摘要：
良性前列腺增生（BPH）影响大量男性，可以通过行为治疗，medical,或手术治疗。药物治疗的最新补充是用于过度活跃的下尿路症状的β3-激动剂。在过去的十年中，多种新的手术治疗方法已经出现，包括几种基于临床的微创手术技术(例如，UroLift,Rezum,OptilumeBPH),或治疗(如，水消融,单端口机器人)，和前列腺动脉栓塞。选项的增长使提供者能够更好地根据特定的疾病因素和患者偏好定制BPH治疗。
